BDNF and Parkinson disease: In our study, the serum level of mBDNF remained significantly lower while that of proBDNF remained significantly higher in patients with early PD than in the control subjects even when the diagnosis of PD has been corrected at follow-up, indicating the reliability of mBDNF as a biomarker for PD.